Business · 09/01/2017
FDA Extends Comment Period for Revised Draft Guidance
The FDA is extending the comment period for the revised draft guidance on quality metrics data, allowing interested persons more time to submit comments in response to requests from the Agency.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →